 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Meyenburg Jason Patrick
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-09-06 Purchase | 2017-09-08 4:40 pm | Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer | 4,000 | $12.13 | $48,500 | 30,228 (Direct) | View |
| 2021-05-14 Purchase | 2021-05-18 4:45 pm | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 13,000 | $9.4561 | $122,929 | 13,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-02-13 Disposition | 2018-02-13 4:41 pm | N/A N/A | Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer | 30,228 | $18 | 0 (Direct) | View |
| 2018-02-13 Disposition | 2018-02-13 4:41 pm | N/A 2027-04-03 | Sucampo Pharmaceuticals Inc. | SCMP | Meyenburg Jason Patrick Chief Commercial Officer | 150,000 | $7.35 | 0 (Direct) | View |
| 2021-02-05 Option Award | 2021-04-07 4:03 pm | N/A 2031-02-04 | Gemini Therapeutics Inc. | GMTX | Meyenburg Jason Patrick CEO | 1,124,832 | $0 | 1,124,832 (Direct) | View |